Dr. Malkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Avenue
CA-51
Cleveland, OH 44195Phone+1 216-445-3830Fax+1 216-444-0924- Is this information wrong?
Summary
- Dr. Mark Malkin is a neuro-oncologist in Cleveland, OH. He received his medical degree from the University of Toronto Faculty of Medicine. He did his residency in neurology at the University of Toronto, and his fellowship in neuro-oncology at Memorial Sloan-Kettering Cancer Center. He has been in practice 44 years. He specializes in neuro-oncology and is experienced in patient care, clinical research, epidemiology, and quality of life studies.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 1985 - 1988
- Sunnybrook Medical Centre, University of Toronto, Toronto, Ontario, CanadaInternship, Straight Internship in Medicine, 1979 - 1980
- University of Toronto Faculty of MedicineClass of 1979
- University College, Faculty of Arts and Sciences, University of TorontoBachelors, Pre-Medical Studies, 1973 - 1975
Certifications & Licensure
- OH State Medical License 2022 - 2026
- VA State Medical License 2013 - 2024
- WI State Medical License 2004 - 2013
- NY State Medical License 1987 - 2005
Awards, Honors, & Recognition
- Robert & Kathryn Lamborn Endowed Chair in Neuro-Oncology Research Cleveland Clinic, 2022
- Regional Top Doctor Castle Connolly, 2014-2022
- Highest Evaluation Teaching Award, M3 Neurology Clerkship Virginia Commonwealth University, 2019
- Join now to see all
Clinical Trials
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma Start of enrollment: 2013 Apr 11
- Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2015 Feb 13
Publications & Presentations
PubMed
- Disease-Based Prognostication: Neuro-Oncology.Kristin A Waite, Gino Cioffi, Mark G Malkin, Jill S Barnholtz-Sloan> ;Seminars in Neurology. 2023 Oct 1
- 5 citationsManaging cancer and living meaningfully (CALM) in adults with malignant glioma: a proof-of-concept phase IIa trial.Ashlee R Loughan, Kelcie D Willis, Sarah Ellen Braun, Gary Rodin, Autumn Lanoye, Alexandria E Davies, Dace Svikis, Suzanne Mazzeo, Mark Malkin, Leroy Thacker> ;Journal of Neuro-Oncology. 2022 May 1
- 10 citationstRNA Function and Dysregulation in Cancer.Tania Gupta, Mark G Malkin, Suyun Huang> ;Frontiers in Cell and Developmental Biology. 2022 Jan 1
- Join now to see all
Journal Articles
- The use of plasma exchange in Hashimoto’s encephalopathy: A case report and review of the literatureCook MK, Malkin M, Karafin MS, J Clin Apheresis, 1/12/2014
- Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade gliomaSchmainda KM, Prah M, Connelly J, Rand SD, Hoffman RG, Mueller W, Malkin MG, Neuro Oncol, 1/1/2014
- PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cellsRoberts JL, Booth L, Conley A, Cruickshanks N, Malkin M, Kukreja RC, Grant S, Poklepovic A, Dent P, Cancer Biol Ther, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Reduced diffusion and perfusion in bevacizumab-induced diffusion restricted necrosis versus brain tumor hypercellularityLaViolette PS, Cochran E, Cohen AD, Al-Gizawiy MA, Connelly J, Rand SD, Malkin MG, Schmainda KM, 21st Annual Meeting of the International Society of magnetic Resonance in Medicine (ISMRM), Salt Lake City, UT, 1/1/2013
- DSC-MRI measures of standardized rCBV predict response to bevacizumab in high-grade brain tumor patientsSchmainda KM, Prah MA, Rand SD, Connelly J, Paulson ES, LaViolette PS, Mueller W, Malkin MG, 21st Annual Meeting of the International Society of magnetic Resonance in Medicine (ISMRM), Salt Lake City, UT, 1/1/2013
- ICA-DSC derived AVOL, a new imaging biomarker of brain tumor vasculatureLaViolette PS, Cohen AD, Cochran E, Prah MA, Rand SD, Connelly J, Malkin MG, Mueller WM, Schmainda KM, Medical College of Wisconsin Research Day, 1/1/2013
- Join now to see all
Lectures
- Advanced Imaging in Neuro-oncology and Current Standard of Care for GlioblastomaPetersburg, VA - 1/20/2014
- Advanced MRI Techniques and Current Standard of Care for Glioblastoma MultiformeFredericksburg, VA - 1/18/2014
- Clinical Trials in Neuro-oncology: Current StatusGlen Allen, VA - 1/12/2014
- Join now to see all
Press Mentions
- Brain Tumor Headache Medical AdviceOctober 24th, 2022
- Reynolds Jr. Chair in Neuro-Oncology Propels Work of Mark G. MalkinSeptember 26th, 2017
- Neuro-Oncologists Help More Patients Win Brain Cancer BattleJanuary 12th, 2017
- Join now to see all
Professional Memberships
- Member
- Member
- Society for Neuro-oncologyMember
Hospital Affiliations
- Cleveland ClinicCleveland, Ohio
Industry Relationships
- Consultant, Worldwide Clinical Trials
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: